We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topics
Collection content
305 result(s) found, displaying 291 to 300
-
Media releasesThe TGA has issued two infringement notices to Peter Evans' company totalling $25,200 for alleged breaches of therapeutic goods legislation in relation to the promotion of a 'BioCharger' device
-
Media releasesThe TGA has issued infringement notices totalling $25,200 to Queensland company CK Surgitech for alleged breaches relating to COVID-19 test kits
-
Media releasesThe TGA has issued an infringement notice for $2,520 to a woman in Western Australia for alleged breaches relating to COVID-19 test kits
-
Media releasesThe TGA has issued an infringement notice for $12,600 to Labtest Direct for the alleged advertising of COVID-19 Rapid Test kits
-
News articlesThis specification describes the minimal acceptable performance and desired features for a ventilator to be used in Australian hospitals during the current SARS-CoV2 outbreak.
-
Media releasesThe TGA has issued Oxymed Australia Pty Ltd five infringement notices for alleged advertising breaches
-
Safety alertsWe have investigated a report that intravenous high-dose vitamin C may be beneficial in the management of COVID-19
-
Media releasesThe TGA will take action in relation to the illegal advertising of therapeutic goods, including those that make false and misleading claims about preventing or curing COVID-19
-
Safety alertsOnly certain types of specialists will be able to prescribe hydroxychloroquine to new patients
-
Scheduling decisions (final)Amendments in relation to hydroxychloroquine and salbutamol